<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55001808"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<docTitle>
	<titlePart>STAR TM Multimer Reagents<lb/> TCR MART-1-PE<lb/></titlePart>
	</docTitle>

	<div type="introduction"> For Research Use Only. Not For Use in Diagnostic Procedures.<lb/> Insert No. I-TCRER1 Rev 0-0307<lb/>PRODUCT OPTIONS<lb/> Size Catalog Number<lb/> 20 reactions<lb/> 50 reactions<lb/> 150 reactions<lb/> 500 reactions<lb/>

	TCR-ER1-0020<lb/> TCR-ER1-0050<lb/> TCR-ER1-0150<lb/> TCR-ER1-0500<lb/></div>

	<note type="other">Manufactured by: </note>

	<byline>
	<affiliation>Altor BioScience Corp. <lb/></affiliation>
	</byline>

	<address>@BULLET 2810 N.Commerce Parkway @BULLET Miramar, FL 33025 USA @BULLET</address>

	<note type="copyright">© 2007 Altor BioScience Corporation All Rights Reserved. Made in U.S.A. Printed in U.S.A.<lb/></note>

	<phone>For technical support or customer service call:U.S. 1-954-443-8600 or contact us through</phone>

	<email>email: sales@altorbioscience.com<lb/></email>

	<div type="introduction">TCR MART-1-PE Staining Kits contain TCR MART-1 reagent labeled<lb/> with PE, Peptide Loading Enhancer (Cat. # PLE-001), HLA-A2.1 control<lb/> cells loaded with MART-1:26-35(27L) peptide (positive control) (Cat. #<lb/> CA2-AE1-1000) and HLA-A2.1 control cells-no peptide (negative<lb/> control) (Cat. # CA2-XC1-1000).<lb/> REAGENT SPECIFICITY<lb/> MHC Allele: HLA-A*0201<lb/> Peptide: Human MART-1/MelanA :26-35(27L) analog: ELAGIGILTV<lb/> DESCRIPTION<lb/> STAR™ multimers are recommended for use in identification and<lb/> quantification of peptide/MHC complexes on the surface of cells and<lb/> tissues and for identification, enumeration and tracing of specific antigen<lb/> presenting cells. STAR™ multimers consist of soluble recombinant<lb/> single chain TCR protein that has been biotinylated and multimerized<lb/> with labeled streptavidin (1). The TCR MART-1 reagent contains a high<lb/> affinity TCR recognizing MART-1:26-35(27L)/HLA-A2.1 complexes.<lb/> Binding to MART-1:27-35 (AAGIGILTV)/HLA-A2.1 complexes on<lb/> peptide-loaded antigen presenting cells is also detectable but requires<lb/> higher concentrations of loaded peptide.<lb/> USAGE</div>

		</front>
	</text>
</tei>
